Real-time enrollment status for this parkinson disease (pd) clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 7:45 AM UTC
| NCT Number | NCT07176286 |
| Recruiting Status | Recruiting |
| Condition | Parkinson Disease (PD) |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) |
| Last Updated on CT.gov | July 1, 2026 (Jul 1, 2026) |
As of September 7, 2026: Clinical trial NCT07176286 is currently recruiting participants. This phase2 study for parkinson disease (pd) is actively seeking new participants at 1 location across the United States. The study is sponsored by Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07176286 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07176286 was last updated Jul 1, 2026 (July 1, 2026). HelloStudys verifies this status automatically.